Therapeutic targeting of the cGAS-STING pathway in human disease
The cyclic GMP-AMP synthase–stimulator of interferon genes (cGAS-STING) pathway is a central regulator of innate immunity that links cytosolic DNA sensing to type I IFN and inflammatory responses…
Read the full articleYou might also wanna read
Rational design of carbazole-based STING inhibitors for treating cGAS-STING pathway-driven inflammatory disorders
Carbazole-based STING inhibitor DDO-88109 demonstrated potential in targeting autoimmune inflammation, with enhanced specificity and reduced
Cdh1 stabilizes STING to boost innate immune activation in renal cell carcinoma, study finds
The E3 ubiquitin ligase APC/C with its coactivator Cdh1 is generally considered to be a tumor suppressor, regulating genome stability and th
scim.ag·20d ago
Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
Wang et al. designed a sCAR-T to overcome solid tumor heterogeneity and the tumor microenvironment. The fusion of scFv with ligands enables
https://www.cell.com/cell/fulltext/S0092-8674(26)00344-2
New insights reveal how 2'3'-cGAMP triggers membrane shearing via 3TM-SMODS, enhancing phage immunity through novel cyclic-nucleotide-activa
ADAM17-mediated AIR motif enables T cell-autonomous control of CAR signaling and receptor shedding
AIR, a minimal 15-amino acid motif, enables rapid, activation-dependent shedding of surface receptors through ADAM17, allowing T cells to au
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
We’re launching a new 27 billion parameter foundation model for single-cell analysis built on the Gemma family of open models.
blog.google·9mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.